Skip to content
10-Q

Quarterly Report

PharMerica CORP

0001388195-17-000007

← back to feed
Filed
May 10, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · Apr 29, 2017 31.09M sh
Shares Diluted Q1 2017 · Mar 31, 2017 31.2M sh
Shares Diluted Q1 2017 · Mar 31, 2016 30.92M sh
Capex Q1 2017 · Mar 31, 2017 $7.9M
Capex Q1 2017 · Mar 31, 2016 $5.4M
Long Term Debt Q1 2017 · Mar 31, 2017 $451M
Long Term Debt Q1 2017 · Dec 31, 2016 $457.8M
Short Term Debt Q1 2017 · Mar 31, 2017 $15.5M
Short Term Debt Q1 2017 · Dec 31, 2016 $15.6M
Cash And Equivalents Q1 2017 · Mar 31, 2017 $15.4M
Cash And Equivalents Q1 2017 · Dec 31, 2016 $5.4M
Cash And Equivalents Q1 2017 · Mar 31, 2016 $25.5M
Cash And Equivalents Q1 2017 · Dec 31, 2015 $23.1M
Stockholders Equity Q1 2017 · Mar 31, 2017 $550.4M
Stockholders Equity Q1 2017 · Dec 31, 2016 $544.2M
Current Liabilities Q1 2017 · Mar 31, 2017 $161.2M
Current Liabilities Q1 2017 · Dec 31, 2016 $182.3M
Current Assets Q1 2017 · Mar 31, 2017 $468.8M
Current Assets Q1 2017 · Dec 31, 2016 $516.7M
Total Assets Q1 2017 · Mar 31, 2017 $1.25B
Total Assets Q1 2017 · Dec 31, 2016 $1.27B
Eps Diluted Q1 2017 · Mar 31, 2017 $0.11
Eps Diluted Q1 2017 · Mar 31, 2016 $0.13
Eps Basic Q1 2017 · Mar 31, 2017 $0.11
Eps Basic Q1 2017 · Mar 31, 2016 $0.13
Sga Expense Q1 2017 · Mar 31, 2017 $63.5M
Sga Expense Q1 2017 · Mar 31, 2016 $57M
Net Income Q1 2017 · Mar 31, 2017 $3.5M
Net Income Q1 2017 · Mar 31, 2016 $4.1M
Operating Income Q1 2017 · Mar 31, 2017 $9.2M
Operating Income Q1 2017 · Mar 31, 2016 $7.9M
Gross Profit Q1 2017 · Mar 31, 2017 $87.9M
Gross Profit Q1 2017 · Mar 31, 2016 $82M
Cost Of Revenue Q1 2017 · Mar 31, 2017 $478.9M
Cost Of Revenue Q1 2017 · Mar 31, 2016 $442.5M
Revenue Q1 2017 · Mar 31, 2017 $566.8M
Revenue Q1 2017 · Mar 31, 2016 $524.5M